Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma.

MLA

Pritchard, Jessica E., et al. “Association between Cognitive Impairment and Oral Anticancer Agent Use in Older Patients with Metastatic Renal Cell Carcinoma.” Journal of the American Geriatrics Society, vol. 70, no. 8, Aug. 2022, pp. 2330–43. EBSCOhost, https://doi.org/10.1111/jgs.17826.

APA

Pritchard, J. E., Wilson, L. E., Miller, S. M., Greiner, M. A., Cohen, H. J., Kaye, D. R., Zhang, T., & Dinan, M. A. (2022). Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma. Journal of the American Geriatrics Society, 70(8), 2330–2343. https://doi.org/10.1111/jgs.17826

Chicago

Pritchard, Jessica E., Lauren E. Wilson, Samuel M. Miller, Melissa A. Greiner, Harvey Jay Cohen, Deborah R. Kaye, Tian Zhang, and Michaela A. Dinan. 2022. “Association between Cognitive Impairment and Oral Anticancer Agent Use in Older Patients with Metastatic Renal Cell Carcinoma.” Journal of the American Geriatrics Society 70 (8): 2330–43. doi:10.1111/jgs.17826.